Regeneron Pharmaceuticals Inc. Stock
Regeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Pros and Cons of Regeneron Pharmaceuticals Inc. in the next few years
Pros
Cons
Performance of Regeneron Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | -1.700% | 2.399% | 7.342% | -10.766% | -6.623% | -10.399% | 59.535% |
| Incyte Corp. | -1.780% | -7.654% | -12.952% | 20.154% | 23.737% | 4.030% | 21.265% |
| Exact Sciences | 0.300% | -0.369% | 46.584% | 44.720% | 59.011% | 100.533% | -19.111% |
| Amgen Inc. | -0.630% | -4.430% | -6.702% | 3.419% | 8.062% | 3.064% | 44.292% |
Comments
News
Should You Buy This Biotech Stock That Just Gained 5% in 1 Day?
Shares of Regeneron Pharmaceuticals (NASDAQ: REGN), a biotech giant, have been southbound over the past two years as the company navigates challenges to one of its main growth drivers, Eylea. This
1 Reason Why Shares of Regeneron Pharmaceuticals Are Surging This Month
After climbing 2.3% in October, the S&P 500 has taken a U-turn and driven steadily lower over the past few weeks. From the start of November through Nov. 21, the index has dipped about 3.5%.
But
2 Beaten-Down Stocks That Could Be About to Rally
What's better than investing in a stock with a promising outlook? Investing in a beaten-down stock with a promising outlook. Scooping up shares of great companies after they have experienced